BioPharma Services >> Bioanalysis >> Resources

Eurofins Bioanalytical Services Downloads

Sidebar Image

Booklets and Flyers

 

Bioanalytical Services Booklet Testing Services for Large Molecule Drug Development
Bioanalytical Services Flyer Immunogenecity, Pharmacokinetics, Biosimilars & Biomarkers
Qualified Flow Cytometry Flyer

Qualified Flow Cytometry Immunophenotyping Assays for Use in Clinical Trials

V-Plex Flyer

A Fully-Validated 10-analyte Multiplex for Quantitation of Human Cytokines

ADC Bioanalysis Global, insightful ADC Bioanalysis from the Large Molecule Experts
Trastuzumab ADA An ELISA for the Detection of Antibodies to Trastuzumab in Human Serum
Trastuzumab ADCC A flow cytometry-based antibody-dependent cell-mediated cytotoxicity (ADCC) assay to measure the potency of trastuzumab
Trastuzumab Characterization Methods to Determine the Binding of Trastuzumab to Fc receptors and Complement C1q
Trastuzumab HER2 Methods to Determine the Binding of Trastuzumab to HER2
Trastuzumab PK A Bridging ELISA for the Quantitative Determination of Trastuzumab (Herceptin®) in Human and Mouse Serum

 

Posters  

 

Validating Flow Cytometry Assays for Use During Clinical Trial Biomarker Assessments

 

David Lanham, Minesh Patel, Theodore Baginski, John Kamerud, Craig Draper
Eurofins Bioanalytical Services et. al.

 

Overcoming Challenges for Flow Cytometry in Clinical Regulated Biomarker Analysis

 

 Minesh Patel and David Lanham
Eurofins Bioanalytical Services et. al. 

 

Phenotypic Characterization of Leucine-rich Repeat Kinase 2 (LRRK2) Knockout Rat Model: A Multi Parameter Cross Platform Biomarker Study

 

Nann Green , Zheng Feng,  Sirosh Bokhari,  Steven Jacobs, Ted Baginski, Aaron McCoy, Athena Bast, Jim Nuckolls , Doug Cortner , Kevin Gamber*, and Craig Draper*
Eurofins Bioanalytical Services et. al.

 

Development of Method for Detection of Anti-Drug Antibodies to Bevacizumab in the Presence of Soluble VEGF

 

 Margaret Snow , Darren Edgar, Abbie Wong,  Fred McCush, John Kamerud,
Eurofins Bioanalytical Services et. al. 

 

Novel Approach to Immunogenicity Testing for Therapeutics with High Prevalence of Pre-Existing Antibodies

 

 Margaret Snow , Scott Nowak, Diane Werth,  James Harness, John Kamerud, Ron Bowsher , Jeff Sailstad, Christopher Brooks, James Zabrecky
Eurofins Bioanalytical Services et. al. 

 

Recommendations for Demonstrating Equivalency of Ready to Assay Cells in Neutralizing Antibody (NAb) Methods Post-Validation

 

 Maria Johns, Diane Werth, John Kamerud*, Mark Baganoff, Maggie Snow, Chris Brooks, Jim Zabrecky , Ron Bowsher , Jeff Sailstad
Eurofins Bioanalytical Services et. al. 

 

Development and Qualification of PK and ADA Methods for Biosimilar Trastuzumab

 

Diane Werth, Sirosh Bokhari, Jessica Lindquist, Abbie Wong, Fred McCush, and John Q Kamerud*
Eurofins Bioanalytical Services et. al. 

 

Overcoming Challenges for Flow Cytometry in Clinical Regulated Biomarker Analysis

 

 Minesh Patel and David Lanham
Eurofins Bioanalytical Services et. al. 

 

GLP Validation of a Gyrolab® Assay for the Determination of Interleukin 8 (IL-8) Levels in Cynomolgus Monkey Serum

 

Theodore Baginski, Mark Abrams, Caroline Green, and John Kamerud
Eurofins Bioanalytical Services et. al.  

 

Immunogenicity analysis: Challenges and Solutions for PEGylated Biopharmaceuticals

 

Matt Bentley, David Shaw and Ray Briggs.
Eurofins Bioanalytical Services et. al.  

 

Challenges in the Transfer of Complex Assay Formats

 

Cheryl McAlpine, Matt Bentley, David Shaw and Ray Briggs
Eurofins Bioanalytical Services et. al.